JXHL1300201 | Atrasentan HCl Tablets | atrasentan | Tablet | Chemical Drugs | Import Drug Application | 2013-06-03 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2014-09-10 | view |
JXHL1300200 | Atrasentan HCl Tablets | atrasentan | Tablet | Chemical Drugs | Import Drug Application | 2013-06-18 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2014-09-10 | view |
JXHL1400103 | ABT-450/ritonavir/ABT-267 film-coated tablet | ABT-45;ritonavir;ABT-267 | Other | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
JXHL1400106 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
JXHL1400105 | ABT-450/ritonavir/ABT-267 film-coated tablet | ABT-45;ritonavir;ABT-267 | Other | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
JXHL1400104 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
JXHL1400170 | ABT-450/ritonavir/ABT-267 film-coated tablet | ABT-45;ritonavir;ABT-267 | Other | Chemical Drugs | Import Drug Application | 2014-06-06 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-09-08 | view |
JYHB1400912 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2014-07-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-01-27 | view |
JYHB1500411 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-04-10 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-05-31 | view |
JYHB1500712 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-05-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-18 | view |
JXSL1500053 | 注射用ABT-414 | depatuxizumab mafodotin | Lyophilized | Biological Products | Import Drug Application | 2015-09-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-04-06 | view |
JXSL1500051 | 注射用ABT-414 | depatuxizumab mafodotin | Lyophilized | Biological Products | Import Drug Application | 2015-09-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-04-06 | view |
JYHB1501395 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-09-28 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-25 | view |
JYHB1501553 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-11-04 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-06-28 | view |
JXHL1500295 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs | Import Drug Application | 2015-12-11 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-08-12 | view |
JXHL1500297 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs | Import Drug Application | 2015-12-11 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-08-12 | view |
JXHL1500296 | ABT-199片 | Venetoclax | Tablet | Chemical Drugs | Import Drug Application | 2015-12-11 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-08-12 | view |
JXHL1600025 | ABT-493/ABT-530片 | glecaprevir;pibrentasvir | Tablet | Chemical Drugs | Import Drug Application | 2016-02-16 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-03-13 | view |
JXHL1600013 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs | Import Drug Application | 2016-02-16 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-11-22 | view |
JXHL1600012 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs | Import Drug Application | 2016-02-16 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-11-22 | view |